California State Teachers Retirement System Boosts Stock Holdings in Tenet Healthcare Corporation $THC

California State Teachers Retirement System raised its holdings in Tenet Healthcare Corporation (NYSE:THC) by 22.1% during the first quarter, Holdings Channel.com reports. The firm owned 102,294 shares of the company’s stock after purchasing an additional 18,504 shares during the quarter. California State Teachers Retirement System’s holdings in Tenet Healthcare were worth $19,304,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD boosted its stake in shares of Tenet Healthcare by 1.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock valued at $1,488,484,000 after buying an additional 119,809 shares in the last quarter. Boston Partners lifted its holdings in Tenet Healthcare by 15.7% in the fourth quarter. Boston Partners now owns 3,642,136 shares of the company’s stock valued at $723,804,000 after acquiring an additional 494,581 shares during the period. AQR Capital Management LLC boosted its position in shares of Tenet Healthcare by 20.3% during the 4th quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock worth $448,419,000 after purchasing an additional 380,116 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in shares of Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after purchasing an additional 157,109 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Tenet Healthcare in the fourth quarter valued at about $248,494,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Stock Up 0.9%

THC stock opened at $254.88 on Friday. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The company’s 50 day simple moving average is $192.10 and its 200-day simple moving average is $199.35. Tenet Healthcare Corporation has a 12 month low of $156.71 and a 12 month high of $262.68. The firm has a market capitalization of $21.96 billion, a PE ratio of 9.83, a P/E/G ratio of 0.97 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities analysts expect that Tenet Healthcare Corporation will post 21.09 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Wells Fargo & Company upped their target price on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. TD Cowen boosted their price target on Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. Raymond James Financial set a $270.00 price target on Tenet Healthcare in a report on Monday, July 27th. Truist Financial lifted their price objective on Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a report on Tuesday, July 28th. Finally, Barclays upped their target price on Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a report on Friday, July 24th. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus price target of $268.50.

Insiders Place Their Bets

In other news, Director Nadja West sold 3,000 shares of the company’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the sale, the director directly owned 24,805 shares in the company, valued at $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Paola M. Arbour sold 10,878 shares of Tenet Healthcare stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $243.90, for a total value of $2,653,144.20. Following the sale, the executive vice president owned 18,413 shares of the company’s stock, valued at approximately $4,490,930.70. This represents a 37.14% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 33,353 shares of company stock valued at $7,683,517. Insiders own 0.97% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.